Want to see IN:COHANCE full AI Analyst Report?

Suven Pharmaceuticals Ltd. (COHANCE) Revenue

3 Followers

Suven Pharmaceuticals Ltd. Revenue

Suven Pharmaceuticals Ltd. had a revenue of 4.22B in the quarter ending Jun 30, 2026, with -31.80%. This bring the company's revenue in the last twelve months to 21.41B, Increased -5.60%. In the fiscal year ending Mar 31, 2026, Suven Pharmaceuticals Ltd. had annual revenue of 22.69B with 89.43% growth.

Revenue (ttm)

21.41B

Revenue Growth

41.24%

P/S Ratio

7.50

Revenue/Employee

₹19,015,507

Employees

1,193

Market Cap

₹170.10B

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Mar 31, 2026	22.69B	10.71B	+89.43%
Mar 31, 2025	11.98B	1.46B	+13.91%
Mar 31, 2024	10.51B	-2.89B	-21.56%
Mar 31, 2023	13.40B	201.07M	+1.52%
Mar 31, 2022	13.20B	3.11B	+30.75%
Mar 31, 2021	10.10B	1.76B	+21.10%
Mar 31, 2020	8.34B	-730.13M	-8.05%
Mar 31, 2019	9.07B	―	―